Response to "Reply to [18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma" by Hutterer et al.

[18F]-fluoro-ethyl-l-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma

(2013) Markus Hutterer et al.   NEURO-ONCOLOGY

MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET?

(2012) Nathalie L. Jansen et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Is there a place for FET PET in the initial evaluation of brain lesions with unknown significance?

(2010) Robert Pichler et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Standards for PET Image Acquisition and Quantitative Data Analysis

(2009) R. Boellaard   JOURNAL OF NUCLEAR MEDICINE

The quantification of dynamic FET PET imaging and correlation with the clinical outcome in patients with glioblastoma

(2009) Frank Thiele et al.   PHYSICS IN MEDICINE AND BIOLOGY

Glioma Proliferation as Assessed by 3'-Fluoro-3'-Deoxy-L-Thymidine Positron Emission Tomography in Patients with Newly Diagnosed High-Grade Glioma

(2008) R. Ullrich et al.   CLINICAL CANCER RESEARCH

Axl and Growth Arrest Specific Gene 6 Are Frequently Overexpressed in Human Gliomas and Predict Poor Prognosis in Patients with Glioblastoma Multiforme

(2008) M. Hutterer et al.   CLINICAL CANCER RESEARCH

Correlation of F-18-fluoro-ethyl-tyrosin uptake with vascular and cell density in non-contrast-enhancing gliomas

(2008) Florian Stockhammer et al.   JOURNAL OF NEURO-ONCOLOGY

[(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma

(2008) Damien C Weber et al.   Radiation Oncology